New search Hide text from Guidelines
A ALIMENTARY TRACT AND METABOLISMA16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
This group comprises all products acting on the alimentary tract and metabolism which cannot be classified in the preceding groups. V03 - All other therapeutic products, should also be considered.
Nutrients are classified in V06 - General nutrients.
A16AX Various alimentary tract and metabolism products
Thioctic acid is classified in this group.
This group includes gene therapy products resulting in the expression of specific proteins.
| The DDD for zinc acetate is expressed as the amount of zinc (Zn). The DDD for nitisinone is based on the treatment of children with a bodyweight of 20 kg. The DDD for thioctic acid is based on the treatment of patients with peripheral diabetic polyneuropathy. The DDD for miglustat is based on the treatment of Gauchers disease. |
| ATC code | Name | DDD | U | Adm.R | Note |
| A16AX01 | thioctic acid | 0.6 | g | O | |
| 0.6 | g | P | |||
| A16AX02 | anethole trithione | ||||
| A16AX03 | sodium phenylbutyrate | 20 | g | O | |
| A16AX04 | nitisinone | 20 | mg | O | |
| A16AX05 | zinc acetate | 0.15 | g | O | |
| A16AX06 | miglustat | 0.3 | g | O | |
| A16AX07 | sapropterin | ||||
| A16AX08 | teduglutide | 5 | mg | P | |
| A16AX09 | glycerol phenylbutyrate | 15 | g | O | |
| A16AX10 | eliglustat | 0.168 | g | O | |
| A16AX11 | sodium benzoate | ||||
| A16AX12 | trientine | 0.45 | g | O | Expressed as trientine |
| A16AX13 | uridine triacetate | ||||
| A16AX14 | migalastat | 61.5 | mg | O | |
| A16AX15 | telotristat | 0.75 | g | O | |
| A16AX16 | givosiran | ||||
| A16AX17 | triheptanoin | ||||
| A16AX18 | lumasiran | ||||
| A16AX19 | fosdenopterin | ||||
| A16AX20 | lonafarnib | ||||
| A16AX21 | elivaldogene autotemcel | ||||
| A16AX22 | tiomolibdic acid | ||||
| A16AX23 | leriglitazone | ||||
| A16AX30 | sodium benzoate and sodium phenylacetate |
Last updated: 2024-01-26